OncoK9 Liquid Biopsy Test Can Enhance Cancer Monitoring in Dogs, New Results Show

PetDx analyses demonstrate the potential of OncoK9 for detection of residual disease following excisional surgery and detection of cancer recurrence following therapy. SAN DIEGO, Jan. 16, 2023 /PRNewswire/ — PetDx® – The Liquid Biopsy Company for Pets™ has released a white paper…

Click here to view original post